BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Moderna Announces Triple Threat Booster Against Viruses

  Moderna is broadening its vaccine horizons once again using mRNA technology and has announced two new vaccine development programs targeting a variety of viruses.

  March 22, 2022

   · 

  2 min read

   · 

  Hayley Shasteen
• 

  Drug Development

  Locus’ Pac-Man-Like Precision Medicine Could Negate Antibiotic Collateral Damage

  Locus Biosciences’ CRISPR-Cas3-enhanced bacteriophage (crPhage™) product attacks harmful bacteria in the microbiome while sparing human cells.

  March 22, 2022

   · 

  4 min read

   · 

  Abbey Glasure
• 

  Business

  Biogen Veteran Alfred Sandrock Named CEO of Voyager Therapeutics

  Less than two months after joining the executive committee of the Voyager Therapeutics Board of Directors, Alfred W. Sandrock Jr. has been named CEO of the company.

  March 22, 2022

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Merck’s Keytruda Adds Advanced Endometrial Carcinoma to Winning Roster

  Merck’s Keytruda has become an approved treatment for yet another indication: unresectable or metastatic advanced endometrial carcinoma. Know more about it here.

  March 22, 2022

   · 

  3 min read

   · 

  Jazmine Colatriano
• 

  Employer Resources

  11 Tips for Managing a Remote Workforce in the Pharma Industry

  In the age of COVID-19, moving to a remote workforce is a necessary but often challenging task. To help, we’ve compiled some tips that can help you while managing a remote workforce.

  March 22, 2022

   · 

  6 min read

   · 

  Franklin Carpenter
• 

  Drug Development

  Aligos Takes Another Hit with Halt of Chronic Hepatitis B Therapy

  Aligos Therapeutics, headquartered in South San Francisco, halted the development of ALG-020572, which was being developed in patients with chronic hepatitis B (CHB).

  March 22, 2022

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Studies Suggest Links Between COVID-19 and Diabetes, Pregnancy Risks and Dementia

  Study after study shows the disease comes with an increased risk of a number of health problems, including diabetes. One of the best ways to avoid those risks is to get vaccinated.

  March 22, 2022

   · 

  5 min read

   · 

  Mark Terry
• 

  FDA

  Biomarkers: a Beacon of Hope for the Future of Alzheimer’s

  Esai, Biogen, Diadem and ProMis all presented their findings on biomarker research at this year’s International Conference on Alzheimer’s and Parkinson’s Diseases.

  March 22, 2022

   · 

  3 min read

   · 

  Hannah Chudleigh
• 

  FDA

  Return of Takeda’s Parathyroid Hormone Injection Delayed Indefinitely

  Takeda faces yet another setback by the U.S. Food and Drug Administration for its parathyroid hormone, natpara.

  March 22, 2022

   · 

  2 min read

   · 

  Hayley Shasteen
• 

  Business

  Antiviral-Focused Aerium Launches with Ex-Takeda Vaccines President at the Helm

  Aerium Therapeutics has officially launched following a successful Series A funding round led by seed investor Omega Funds.

  March 22, 2022

   · 

  2 min read

   · 

  Vanessa Doctor, RN